Frequencies of the D85 and Y85 variants of UGT2B15 in children and adolescent girls with hyperandrogenism

Journal of Pediatric Endocrinology and Metabolism

Volumn 16, Issue 5, 2003, Pages 719-726

  Tomboc, Marlah ^a   Witchel, Selma Feldman ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Glucuronidation; Hyperandrogenism; Polycystic ovary syndrome; Premature adrenarche; Premature pubarche; UGT enzymes

Indexed keywords

AMINO ACID; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; ASPARTIC ACID; DNA; GLUCURONOSYLTRANSFERASE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TYROSINE; ANDROSTANE 3,17 DIOL GLUCURONIDE; ANDROSTANE-3,17-DIOL GLUCURONIDE; DRUG DERIVATIVE; UDP GLUCURONOSYLTRANSFERASE 2B15, HUMAN; UDP-GLUCURONOSYLTRANSFERASE 2B15, HUMAN;

ADOLESCENT; ANDROGEN METABOLISM; ANDROGEN SYNTHESIS; ARTICLE; CLINICAL FEATURE; CODON; CONTROLLED STUDY; DNA MODIFICATION; ENZYME SPECIFICITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCURONIDATION; HIRSUTISM; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MALE; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PRECOCIOUS PUBERTY; PROTEIN FAMILY; RISK FACTOR; BLOOD; CHILD; GENETICS; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; METABOLISM; PHENOTYPE;

ADOLESCENT; ANDROSTANE-3,17-DIOL; ANDROSTENEDIONE; CHILD; DIHYDROTESTOSTERONE; FEMALE; GENE FREQUENCY; GENOTYPE; GLUCURONOSYLTRANSFERASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPERANDROGENISM; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PUBERTY, PRECOCIOUS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 0141685896     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Reiter E, Saenger P. Premature adrenarche. Endocrinologist 1997; 7: 85-88.
2. Ibañez L, DiMartino-Nardi J, Potau N, Saenger P. Premature adrenarche - nonnal variant or forerunner of adult disease? Endocr Rev 2000; 21: 671-696.
3. Ibañez L, Potau N, Zampolli M, Street M, Carrascosa A. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages ofpuberty: evidence from gonadotropin releasing hormone agonist testing. Fertil Steril 1997; 67: 849-855.
4. Knochenhauer ES, Key TJ, Kahsar-Miller M, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the Southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082.
5. rd, Fox J, Dunaif A. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci 1998; 95: 14956-14960.
6. Hague WM, Adams J, Reeders ST, Peto TEA, Jacobs HS. Familial polycystic ovaries: a genetic disease? Clin Endocrinol 1988; 29: 593-605.
7. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R, McCarthy M. The genetic basis of polycystic ovary syndrome. Hum Reprod 1997; 12: 2641-2648.
8. Dahlgren E, Janson PO. Polycystic ovary syndrome - long-term metabolic consequences. Int J Gynecol Obstet 1994; 44: 3-8.
9. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N, Lundberg PA. Women with polycystic ovary syndrome wedge resected in 1956-1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992; 57: 505-513.
10. Talbott E, Guzich D, Clerici A, Berga S, Detre K, Weimer K, Kuller L. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscl Thromb Vasc Biol 1995; 15: 821-826.
11. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
12. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaannieimi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
13. Gharani N, Waterworth DM, Batty S, White D, Gilling-Smith C, Conway GS, McCarthy M, Franks S, Williamson R. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism. Hum Mol Genet 1997; 6: 397-402.
14. Waterworth DM, Bennett ST, Gharani N, McCarthy MI, Hague S, Batty S, Conway GS, White D, Todd JA, Franks S, Williamson R. Linkage and association of insulin gene FNTR regulatory polymorphism with polycystic ovary syndrome. Lancet 1997; 349: 986-990.
15. rd , Spielman RS, Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci 1999; 96: 8573-8578.
16. Talbot JA, Bicknell EJ, Rajkhowa M, Krook A, O'Rahilly S, Clayton RN. Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 1996; 81: 1979-1983.
17. Cohen DP, Stein EM, Li Z, Matulis CK, Ehrmann DA, Layman LC. Molecular analysis of the gonadotropin-releasing hormone receptor in patients with polycystic ovary syndrome. Fertil Steril 1999; 72: 360-363.
18. Gharani N, Waterworth DM, Williamson R, Franks S. 5′ polymorphism of the CYP17 gene is not associated with serum testosterone levels in wornen with polycystic ovaries [Letter]. J Clin Endocrinol Metab 1996; 81: 4174.
19. Liao WX, Roy AC, Ng SC. Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome. Mol Hum Reprod 2000; 6: 587-590.
20. Witchel SF, Aston CE. The role of heterozygosity for CYP21 in polycystic ovary syndrome. J Pediatr Endocrinol Metab 2000; 13 (Suppl 5): 1315-1317.
21. Escobar-Morreale HF, San Millan JL, Smith RR, Sancho J, Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute wornen: phenotype-genotype correlations. Fertil Steril 1999; 72: 629-638.
22. Blanche H, Vexiau P, Clauin S, Le Gall I, Fiet J, Mornet E, Dausset J, Bellanne-Chantelot C. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women. Hum Genet 1997; 101: 56-60.
23. Labrie F. Intracrinology. Mol Cell Endocrinol 1991; 78: C113-C118.
24. Bélanger A, Hum DW, Beaulieu M, Lévesque E, Guillemette C, Tchemof A, Bélanger G, Turgeon D, Dubois S. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol 1998; 65: 301-310.
25. Mackenzie PI, Mojarrabi B, Meech R, Hansen A. Steroid UDP glucuronyltransferases: characterization and regulation. J Endocrinol 1996; 150: S79-86.
26. Kirschner MA, Samojlik E, Szmal E. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism. J Clin Endocrinol Metab 1987; 65: 597-601.
27. Rittner HL, Lee PD, Blum WF, Doerr HG, Steiss J, Kreuder J, Rascher W, Kiess W. Developmental patterns of serum 3α-androstanediol glucuronide. J Endocrinol Invest 1997; 20: 245-250.
28. Lopes LA, Catzeflis C, Cicotti I, Rey C, Sizonenko PC. Plasma 3α-androstanediol glucuronide in normal children and in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 1997; 48: 35-40.
29. Lévesque E, Beaulieu M, Green M, Tephly T, Bélanger A, Hum D. Isolation and characterization of UGT21315 (Y85); a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 1997; 7: 317-325.
30. Ehrmann DA, Rosenfield RL. An endocrinologic approach to hirsutism. J Clin Endocrinol Metab 1990; 71: 1-4.
31. Witchel SF, Fagerli J, Siegel J, Smith R, Mitwally MF, Lewy V, Arslanian S, Lee PA. No association between body mass index and β3-adrenergic receptor variant (W64R) in children with premature pubarche and adolescent girls with hyperandrogenism. Fertil Steril 2000; 73: 509-515.
32. Beaulieu M, Lévesque E, Hum D, Bélanger A. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem 1996; 271: 22855-22862.
33. Chen F, Ritter JK, Wang MG, McBride OW, Lubet RA, Owens IS. Characterization of a cloned human dihydro-testosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochemistry 1993; 32: 10648-10657.
34. Green M, Oturu EM, Tephly TR. Stable expression of a human liver UDP-glucuronosyltransferase (UGT21315) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos 1994; 22: 799-805.
35. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP, Chowdhury NR. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase I in Gilbert's syndrome. N Engl J Med 1995; 333: 1171-1175.
36. Raijimakers MT, Jansen PL, Steegers EA, Peters WH. Association of human liver bilirubin UDP-glucurono-syltransferase activity with a polymorphism in the promoter region of the UGTIAI gene. J Hepatol 2000; 33: 348-351.
37. Yoshihiro M, Nishizawa K, Sato H, Sawa H, Shimada M. Prolonged unconjugated hyperbilirubinernia associated with breast milk and mutations of the bilirubin uridine diphosphate glucuronosyltransferase gene. Pediatrics 2000; 106: e59.
38. Maruo Y, Nishizawa K, Sato, H, Doida Y, Shimada M. Association of neonatal hyperbilirubineinia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999; 103: 1224-1227.
39. Bancroft JD, Kreamer B, Gourley GR. Gilbert-syndrome accelerates development of neonatal jaundice. J Pediatr 1998; 132: 656-660.
40. Del Giudice EM, Perrotta S, Nobili B, Specchia C, d'Urzo G, lolascon A. Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 1999; 94: 2259-2262.
41. Kaplan M, Renbaum P, Levylahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency - a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci 1997; 94: 12128-12132.
42. Galanello R, Cipollina MD, Dessi C, Giagu N, Lai E, Cao A. Co-inherited Gilbert's syndrome: a factor determining hyperbilirubinemia in homozygous beta-thalassemia. Haematologica 1999; 84: 103-105.
43. Strassburg CP, Vogel A, Kneip S, Tukey RH, Manns MP. Polymorphisms of the human UDP-glucurono-syltransferase (UGT)1A7 gene in colorectal cancer. Gut 2002; 50: 851-856.
44. MacLeod SL, Nowell S, Plaxco J, Lang NP. An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer. Ann Surg Oncol 2000; 7: 777-782.
45. Turgeon D, Carrier JS, Lévesque E, Hum DW, Bélanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 2001; 142: 778-787.
46. Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med 1997; 62: 151-158.
47. Nayak S, Lee PA, Witchel SF. Variants of the type II 3β-hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents. Mol Genet Metab 1998; 64: 184-192.
48. Witchel SF, Smith R, Tomboc M, Aston CE. Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril 2001; 75: 724-730.